Ma Ying-lung (600993.SH) is a recognized by the Ministry of Commerce of the first old Chinese company, founded in AD 1582. Over the years, Ma Ying-long commitment to the professional development of the pharmaceutical industry, adhere to the anorectal area as the core positioning hemorrhoid treatment, after years of sustained, rapid and healthy development, has now grown to a foot in the pharmaceutical manufacturing, drug development, drug wholesale and retail, hospital chain other fields of professional multi-international companies.

Produced functional and can produce more than 30 dosage forms, for production of more than 300 kinds of 国药准字号 drugs, with more than 20 exclusive species, a total of 18 国药准字号 varieties appeared in the "National Essential Drugs List", 37 varieties appeared in the "national health insurance directory", which Musk Hemorrhoids Ointment, musk hemorrhoids suppository, Pearl ointment, eye ointment Eight Ma Ying-long exclusive products for the company. Advanced production facilities, the main varieties of production lines and supporting facilities of the technical level has been the leading domestic level.

company around the core position to carry out drug development series. Currently, anorectal hemorrhoid treatment products sold to seven species in the research project 3 hemorrhoid treatment, covering ointment, suppository, oral medicine tablets, medicine oral tablet, lotion, capsules, cream gel, gas mist, powder, granule variety of dosage forms, project governance in the study of anorectal hemorrhoids varieties 6 species, other research projects 8. The company also developed a series eye-care drug and cosmetic products, and actively enter the market, drug store, is currently in the research project 11.

staffing company has a neat, well-structured, complementary technical team and a group engaged in the synthesis of pharmaceuticals, herbal extracts, pharmaceutical engineering, and evaluation of pharmacology and toxicology and other aspects of clinical trial subjects leaders. With Peking University College of Pharmacy, China Pharmaceutical University and a number of research institutions to establish a long-term strategic partnership. Approved by the Ministry of Personnel jointly established with Peking University post-doctoral workstations. In 2009, Ma Ying Long Pharmaceutical Group Co., Ltd. Technical Center by the National Development and Reform Commission, Ministry of Science and other five ministries identified as state-level enterprise technical center, Ma Ying-long innovative drug research and development team has been identified as the Hubei Provincial Party Committee Organization Department, the first batch of "key industries in Hubei Province innovation team. "

according to the SFDA Southern Medicine Economic Institute statistics, Ma Ying Long Hemorrhoids drugs in the retail market share of more than 40%, as the first brand of hemorrhoid treatment field.

company has established a relatively complete marketing management system and a nationwide marketing network platform, and the forefront of the domestic pharmaceutical circulation of more than 300 companies have established long-term relationship between the products are exported to Southeast Asia and Europe continent.

Ma Ying-long and its subsidiaries were adopted by the SFDA GMP, GSP quality control system certification, issued by the international authority SGS ISO14000 environmental management system and occupational safety and health management system OHSAS18000 certification, take the lead in the pharmaceutical industry to achieve a "three-certified." In the World Brand Lab, World Executive Weekly joint assessment of the 2010 "China 500 Most Valuable Brands" list, ranked 210 Ma Ying-long, the brand value reached 4.321 billion yuan. In 2005, Ma Ying-long People's Daily, China Enterprise Culture Improvement Association, the China Quality and Brand Magazine and six joint public media selection won the "most influential Chinese hemorrhoid medication brand." In 2006, Ma Ying Long recognized SAIC awarded "China Famous Trademark", the only area in China hemorrhoid treatment "China Famous Brand." In 2009, Ma Ying-Long voted by China Nonprescription Medicines Association, "China OTC brands fifteen strong."

stock in 2004 in Shanghai Stock Exchange, which won the channel and regulate sustainable financing of operating platforms. Stock has been the Shanghai Stock Exchange, China Securities Index Company selected for the sample of Chinese Corporate Governance Index and the Shanghai stock index constituent stocks of social responsibility. The company has honored as "Outstanding Board Award", "The most important shareholders of listed companies", marking the level of access to public corporate governance, securities institutions and experts highly recognized.

four hundred years of history and cultural heritage, the company has gradually formed Mayinglong unique corporate culture system. Companies adhering to the "customers to create a healthy, creation of shareholder wealth, creating opportunities for employees, to create effective" business purposes, promote "true repair heart to xiu as" philosophy, advocated "the sound operation, coordinated development "business concept, advocating" enhanced "values, promote" Ryoma spirit "of the spirit of enterprise. Ma Ying-long mission will be to achieve the modernization of traditional Chinese medicine, the brand management strategy under the guidance of the times and future.